Search
Search Results
##search.searchResults.foundPlural##
-
EPIDEMIOLOGY OF MALARIA IN ENDEMIC AREAS
5419PDF: 2696HTML: 49722 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3694PDF: 1137HTML: 23368 -
ELEVATED P-SELECTIN IN SEVERE COVID-19: CONSIDERATIONS FOR THERAPEUTIC OPTIONS P-Selectine and COVID-19
1939PDF: 732HTML: 243 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1535PDF: 813Suppl. Files: 341Html: 141 -
IS HEMOGLOBIN E GENE WIDELY SPREAD IN THE STATE OF MADHYA PRADESH IN CENTRAL INDIA? EVIDENCE FROM FIVE TYPICAL FAMILIES
1872PDF: 896HTML: 7988Untitled: 208 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1759PDF: 752HTML: 237 -
Fetal hemoglobin modifies the disease manifestation of severe Plasmodium falciparum malaria in adult patients with sickle cell anemia.
3288PDF: 934HTML: 777text and figure: 242 -
LATERAL SINUS THROMBOSIS IN OTOLOGY: A REVIEW
1661PDF: 969HTML: 4168Letter: 185 -
CONTINUOUS CULTURES OF PLASMODIUM FALCIPARUM ESTABLISHED IN TANZANIA FROM PATIENTS WITH ACUTE MALARIA In vitro Malaria cultures
1825PDF: 575HTML: 250 -
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia
7937PDF: 745HTML: 253 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3769PDF: 1274HTML: 3913Untitled: 247Untitled: 281 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2969PDF: 1398HTML: 3719Untitled: 207Untitled: 221Untitled: 195 -
SHORT HISTORY OF MALARIA AND ITS ERADICATION IN ITALY
5026PDF: 1964HTML: 11404Fig 1: 244Fig 2: 202Fig 3: 324Fig 4: 206Fig 5: 207Fig 6: 198Fig 7: 221Fig 8: 200 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1927PDF: 1192HTML: 332 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3488PDF: 1211HTML: 493 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1644PDF: 824HTML: 1275Figure 1: 187Figure 2: 201Figure 3: 198 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2119PDF: 1076HTML: 15732COVER LETTER: 203 -
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
2942PDF: 1132HTML: 3063 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4389PDF: 1406HTML: 2180 -
The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases
935PDF: 715HTML: 359 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8176PDF: 4355HTML: 7526 -
IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma
143PDF: 455HTML: 44







